• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

遗传背景改变尼曼-匹克病 C1 型小鼠模型的表型严重程度和寿命。

Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1.

机构信息

Genomics, Development and Disease Section, Genetic Disease Research Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, MD 20892, USA.

Department of Pharmacology, University of Oxford, Oxford OX1 3QT, UK.

出版信息

Dis Model Mech. 2020 Mar 13;13(3):dmm042614. doi: 10.1242/dmm.042614.

DOI:10.1242/dmm.042614
PMID:31996359
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7075069/
Abstract

Niemann-Pick disease type C1 (NPC1) is a rare, fatal neurodegenerative disorder characterized by lysosomal accumulation of unesterified cholesterol and glycosphingolipids. These subcellular pathologies lead to phenotypes of hepatosplenomegaly, neurological degeneration and premature death. NPC1 is extremely heterogeneous in the timing of clinical presentation and is associated with a wide spectrum of causative mutations. To study the genetic architecture of NPC1, we have generated a new NPC1 mouse model, mutants showed notably reduced NPC1 protein compared to controls and displayed the pathological and biochemical hallmarks of NPC1. Interestingly, mutants on a C57BL/6J genetic background showed more severe visceral pathology and a significantly shorter lifespan compared to mutants on a BALB/cJ background, suggesting that strain-specific modifiers contribute to disease severity and survival. QTL analysis for lifespan of 202 backcross N2 mutants on a mixed C57BL/6J and BALB/cJ background detected significant linkage to markers on chromosomes 1 and 7. The discovery of these modifier regions demonstrates that mouse models are powerful tools for analyzing the genetics underlying rare human diseases, which can be used to improve understanding of the variability in NPC1 phenotypes and advance options for patient diagnosis and therapy.This article has an associated First Person interview with the first author of the paper.

摘要

尼曼-匹克病 C1 型(NPC1)是一种罕见的致命神经退行性疾病,其特征是溶酶体中未酯化胆固醇和糖鞘脂的积累。这些亚细胞病理学导致肝脾肿大、神经退行性变和过早死亡的表型。NPC1 在临床表现的时间上具有极高的异质性,并与广泛的致病突变相关。为了研究 NPC1 的遗传结构,我们生成了一种新的 NPC1 小鼠模型,突变体与对照组相比 NPC1 蛋白显著减少,并表现出 NPC1 的病理学和生物化学特征。有趣的是,与 BALB/cJ 背景相比,C57BL/6J 遗传背景下的 突变体表现出更严重的内脏病理学和明显更短的寿命,表明特定于菌株的修饰因子有助于疾病严重程度和存活。在混合 C57BL/6J 和 BALB/cJ 背景下对 202 个回交 N2 突变体的寿命进行 QTL 分析,检测到与染色体 1 和 7 上的标记物显著连锁。这些修饰区域的发现表明,小鼠模型是分析罕见人类疾病遗传基础的有力工具,可用于改善对 NPC1 表型变异性的理解,并为患者诊断和治疗提供更多选择。本文有该论文第一作者的相关第一人称采访。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04cf/7075069/1b6edb888269/dmm-13-042614-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04cf/7075069/bf7518e219c3/dmm-13-042614-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04cf/7075069/6b0593fe4ca9/dmm-13-042614-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04cf/7075069/61b85f2bd895/dmm-13-042614-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04cf/7075069/85da81679da8/dmm-13-042614-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04cf/7075069/1b6edb888269/dmm-13-042614-g5.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04cf/7075069/bf7518e219c3/dmm-13-042614-g1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04cf/7075069/6b0593fe4ca9/dmm-13-042614-g2.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04cf/7075069/61b85f2bd895/dmm-13-042614-g3.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04cf/7075069/85da81679da8/dmm-13-042614-g4.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/04cf/7075069/1b6edb888269/dmm-13-042614-g5.jpg

相似文献

1
Genetic background modifies phenotypic severity and longevity in a mouse model of Niemann-Pick disease type C1.遗传背景改变尼曼-匹克病 C1 型小鼠模型的表型严重程度和寿命。
Dis Model Mech. 2020 Mar 13;13(3):dmm042614. doi: 10.1242/dmm.042614.
2
In Niemann-Pick C1 mouse models, glial-only expression of the normal gene extends survival much further than do changes in genetic background or treatment with hydroxypropyl-beta-cyclodextrin.在尼曼-皮克C1型小鼠模型中,正常基因仅在神经胶质细胞中的表达比基因背景的改变或用羟丙基-β-环糊精治疗更能显著延长生存期。
Gene. 2018 Feb 15;643:117-123. doi: 10.1016/j.gene.2017.12.006. Epub 2017 Dec 6.
3
Modeling Niemann-Pick disease type C1 in zebrafish: a robust platform for screening of candidate therapeutic compounds.在斑马鱼中建立尼曼-匹克病 C1 型模型:筛选候选治疗化合物的强大平台。
Dis Model Mech. 2018 Aug 15;11(9):dmm034165. doi: 10.1242/dmm.034165.
4
Gastrointestinal Tract Pathology in a BALB/c Niemann-Pick Disease Type C1 Null Mouse Model.BALB/c 尼曼-匹克病 C1 型缺陷小鼠模型的胃肠道病理学。
Dig Dis Sci. 2018 Apr;63(4):870-880. doi: 10.1007/s10620-018-4914-x. Epub 2018 Jan 22.
5
Necroptosis inhibition as a therapy for Niemann-Pick disease, type C1: Inhibition of RIP kinases and combination therapy with 2-hydroxypropyl-β-cyclodextrin.Niemann-Pick 病 C1 型的治疗方法:抑制 RIP 激酶和 2-羟丙基-β-环糊精联合治疗。
Mol Genet Metab. 2018 Dec;125(4):345-350. doi: 10.1016/j.ymgme.2018.10.009. Epub 2018 Oct 30.
6
Sterol O-Acyltransferase 1 (): A Genetic Modifier of Niemann-Pick Disease, Type C1.固醇O-酰基转移酶1():C1型尼曼-匹克病的一种基因修饰因子。
Int J Mol Sci. 2024 Apr 11;25(8):4217. doi: 10.3390/ijms25084217.
7
NPC1 Deficiency in Mice is Associated with Fetal Growth Restriction, Neonatal Lethality and Abnormal Lung Pathology.小鼠NPC1缺乏与胎儿生长受限、新生儿致死率及肺部病理异常有关。
J Clin Med. 2019 Dec 19;9(1):12. doi: 10.3390/jcm9010012.
8
Beneficial effects of primidone in Niemann-Pick disease type C (NPC)-model cells and mice: Reduction of unesterified cholesterol levels in cells and extension of lifespan in mice.苯妥英在尼曼-匹克病 C 型(NPC)模型细胞和小鼠中的有益作用:降低细胞内未酯化胆固醇水平和延长小鼠寿命。
Eur J Pharmacol. 2021 Apr 5;896:173907. doi: 10.1016/j.ejphar.2021.173907. Epub 2021 Jan 24.
9
Npc1 deficiency in the C57BL/6J genetic background enhances Niemann-Pick disease type C spleen pathology.C57BL/6J 遗传背景下 NPC1 缺陷增强尼曼-匹克病 C 型脾病理学。
Biochem Biophys Res Commun. 2011 Sep 30;413(3):400-6. doi: 10.1016/j.bbrc.2011.08.096. Epub 2011 Sep 2.
10
In vivo antisense oligonucleotide reduction of NPC1 expression as a novel mouse model for Niemann Pick type C- associated liver disease.体内反义寡核苷酸降低NPC1表达作为尼曼-皮克C型相关肝病的新型小鼠模型。
Hepatology. 2008 May;47(5):1504-12. doi: 10.1002/hep.22327.

引用本文的文献

1
Exploration of Bromodomain Proteins as Drug Targets for Niemann-Pick Type C Disease.探索溴结构域蛋白作为尼曼-匹克C型病的药物靶点
Int J Mol Sci. 2025 Jun 16;26(12):5769. doi: 10.3390/ijms26125769.
2
sPLA2-IIA modifies progranulin deficiency phenotypes in mouse models.分泌型磷脂酶A2-IIA(sPLA2-IIA)改变小鼠模型中的颗粒蛋白前体缺乏表型。
Mol Neurodegener. 2025 Jun 17;20(1):72. doi: 10.1186/s13024-025-00863-8.
3
Global and Targeted Metabolomics for Revealing Metabolomic Alteration in Niemann-Pick Disease Type C Model Cells.用于揭示尼曼-匹克病C型模型细胞中代谢组学改变的全局和靶向代谢组学

本文引用的文献

1
Different Niemann-Pick C1 Genotypes Generate Protein Phenotypes that Vary in their Intracellular Processing, Trafficking and Localization.不同的尼曼-匹克 C1 基因型产生的蛋白表型在其细胞内加工、运输和定位方面存在差异。
Sci Rep. 2019 Mar 28;9(1):5292. doi: 10.1038/s41598-019-41707-y.
2
Animal models for Niemann-Pick type C: implications for drug discovery & development.尼曼-匹克 C 型动物模型:对药物发现与开发的影响。
Expert Opin Drug Discov. 2019 May;14(5):499-509. doi: 10.1080/17460441.2019.1588882. Epub 2019 Mar 19.
3
R/qtl2: Software for Mapping Quantitative Trait Loci with High-Dimensional Data and Multiparent Populations.
Metabolites. 2024 Sep 24;14(10):515. doi: 10.3390/metabo14100515.
4
Optimization of systemic AAV9 gene therapy in Niemann-Pick disease type C1 mice.尼曼-匹克病C1型小鼠全身腺相关病毒9型基因治疗的优化
bioRxiv. 2024 Jun 8:2024.06.07.597901. doi: 10.1101/2024.06.07.597901.
5
Sterol O-Acyltransferase 1 (): A Genetic Modifier of Niemann-Pick Disease, Type C1.固醇O-酰基转移酶1():C1型尼曼-匹克病的一种基因修饰因子。
Int J Mol Sci. 2024 Apr 11;25(8):4217. doi: 10.3390/ijms25084217.
6
A novel variant and clinical diversity in Vietnamese SMARD1 and CMT2S patients.越南SMARD1和CMT2S患者中的一种新型变异及临床多样性。
Front Pediatr. 2024 Feb 13;12:1165492. doi: 10.3389/fped.2024.1165492. eCollection 2024.
7
Understanding the phenotypic variability in Niemann-Pick disease type C (NPC): a need for precision medicine.了解尼曼-匹克病C型(NPC)的表型变异性:精准医学的必要性。
NPJ Genom Med. 2023 Aug 11;8(1):21. doi: 10.1038/s41525-023-00365-w.
8
Severe neurometabolic phenotype in zebrafish with a C-terminal mutation.具有C端突变的斑马鱼的严重神经代谢表型
Front Mol Neurosci. 2023 Mar 17;16:1078634. doi: 10.3389/fnmol.2023.1078634. eCollection 2023.
9
Organ Weights in Mutant Mice Partly Normalized by Various Pharmacological Treatment Approaches.各种药物处理方法使突变小鼠的器官重量部分恢复正常。
Int J Mol Sci. 2022 Dec 29;24(1):573. doi: 10.3390/ijms24010573.
10
Genetic Background Matters: Population-Based Studies in Model Organisms for Translational Research.遗传背景很重要:用于转化研究的基于群体的模式生物研究。
Int J Mol Sci. 2022 Jul 8;23(14):7570. doi: 10.3390/ijms23147570.
R/qtl2:用于对具有高维数据和多亲本群体进行数量性状基因座定位的软件。
Genetics. 2019 Feb;211(2):495-502. doi: 10.1534/genetics.118.301595. Epub 2018 Dec 27.
4
Lysosomal storage diseases.溶酶体贮积症。
Nat Rev Dis Primers. 2018 Oct 1;4(1):27. doi: 10.1038/s41572-018-0025-4.
5
Controversies on the potential therapeutic use of rapamycin for treating a lysosomal cholesterol storage disease.关于雷帕霉素治疗溶酶体胆固醇贮积病潜在治疗用途的争议。
Mol Genet Metab Rep. 2018 May 12;15:135-136. doi: 10.1016/j.ymgmr.2018.05.001. eCollection 2018 Jun.
6
Heat Shock Proteins and Autophagy Pathways in Neuroprotection: from Molecular Bases to Pharmacological Interventions.热休克蛋白与自噬通路在神经保护中的作用:从分子基础到药物干预。
Int J Mol Sci. 2018 Jan 22;19(1):325. doi: 10.3390/ijms19010325.
7
Approaches to sample size calculation for clinical trials in rare diseases.罕见病临床试验样本量计算方法。
Pharm Stat. 2018 May;17(3):214-230. doi: 10.1002/pst.1848. Epub 2018 Jan 10.
8
In Niemann-Pick C1 mouse models, glial-only expression of the normal gene extends survival much further than do changes in genetic background or treatment with hydroxypropyl-beta-cyclodextrin.在尼曼-皮克C1型小鼠模型中,正常基因仅在神经胶质细胞中的表达比基因背景的改变或用羟丙基-β-环糊精治疗更能显著延长生存期。
Gene. 2018 Feb 15;643:117-123. doi: 10.1016/j.gene.2017.12.006. Epub 2017 Dec 6.
9
Antisense oligonucleotides: the next frontier for treatment of neurological disorders.反义寡核苷酸:治疗神经紊乱的下一个前沿。
Nat Rev Neurol. 2018 Jan;14(1):9-21. doi: 10.1038/nrneurol.2017.148. Epub 2017 Dec 1.
10
Settling the score: variant prioritization and Mendelian disease.清算旧账:变异体优先级排序与孟德尔疾病
Nat Rev Genet. 2017 Oct;18(10):599-612. doi: 10.1038/nrg.2017.52. Epub 2017 Aug 14.